Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Should You Buy?

Eurofins Scient (OTCMKTS:ERFSF) shares gapped up prior to trading on Thursday . The stock had previously closed at $76.35, but opened at $82.22. Eurofins Scient shares last traded at $82.22, with a volume of 6 shares.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on ERFSF shares. BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a research note on Monday, February 2nd. One research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Eurofins Scient has an average rating of “Hold”.

Eurofins Scient Trading Up 2.1%

The business’s 50 day moving average is $79.77 and its 200-day moving average is $75.04. The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77.

About Eurofins Scient

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.